Correlation Between Virax Biolabs and Timber Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Timber Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Timber Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virax Biolabs Group and Timber Pharmaceuticals, you can compare the effects of market volatilities on Virax Biolabs and Timber Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Timber Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Timber Pharmaceuticals.

Diversification Opportunities for Virax Biolabs and Timber Pharmaceuticals

-0.35

Correlation Coefficient

Virax Biolabs  Timber Pharmaceuticals

Very good diversification

The 3 months correlation between Virax and Timber is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Timber Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Timber Pharmaceuticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Timber Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Timber Pharmaceuticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Timber Pharmaceuticals go up and down completely randomly.

Pair Corralation between Virax Biolabs and Timber Pharmaceuticals

If you would invest  172.00  in Timber Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  0.00  from holding Timber Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Virax Biolabs Group  vs.  Timber Pharmaceuticals

Virax Biolabs Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Timber Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Timber Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Timber Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Virax Biolabs and Timber Pharmaceuticals

The main advantage of trading using opposite Virax Biolabs and Timber Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Timber Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will offset losses from the drop in Timber Pharmaceuticals' long position.

The idea behind Virax Biolabs Group and Timber Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..